# Neuroblastoma Precision Trial

> **NCT02868268** · — · ACTIVE_NOT_RECRUITING · sponsor: **New Approaches to Neuroblastoma Therapy Consortium** · enrollment: 93 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **OTHER:** Gene panel sequencing of tumor specimens

## Key facts

- **NCT ID:** NCT02868268
- **Lead sponsor:** New Approaches to Neuroblastoma Therapy Consortium
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08-22
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868268, "Neuroblastoma Precision Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02868268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*